Integra LifeSciences Holdings Corporation (IART)

IART Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-495.34	-6.94	67.74	180.55	169.08	133.89
Depreciation & Amortization	158.09	140.89	123.51	118.3	119.84	116.03
Other Amortization	5.99	5.59	6.16	6.85	7.03	27.49
Loss (Gain) From Sale of Assets	0.65	1.5	0.78	-7.46	-39.56	7.86
Asset Writedown & Restructuring Costs	504.3	12.21	-	-	2.75	0.52
Stock-Based Compensation	19.9	24.38	20.14	27.73	36.21	19.59
Other Operating Activities	-73.91	-17.24	3.19	-22.07	-1.08	-60.23
Change in Accounts Receivable	-15.5	7.4	4.59	-33.91	7.27	52.11
Change in Inventory	-43.99	-28.15	-59.77	-29.12	5.37	-48.35
Change in Accounts Payable	-1.66	-2.67	-20.23	17.34	32.87	-57.51
Change in Unearned Revenue	4.43	3.54	0.13	4.27	0.03	-0.04
Change in Other Net Operating Assets	26.33	-11.12	-6.29	1.99	-27.38	12.48
Operating Cash Flow	89.31	129.38	139.96	264.47	312.43	203.83
Operating Cash Flow Growth	-35.00%	-7.56%	-47.08%	-15.35%	53.28%	-11.93%
Capital Expenditures	-93.82	-104.42	-66.87	-42.34	-48.02	-38.89
Sale of Property, Plant & Equipment	-	-	-	11.15	0	3.66
Cash Acquisitions	4.18	-277.81	-	-51.51	-303.91	-
Divestitures	-	-	-	23.96	190.47	-
Sale (Purchase) of Intangibles	-9.95	-9.95	-	-4.74	-0.06	-25
Investment in Securities	26.75	5.5	-32.69	-	-	-
Other Investing Activities	-4.56	-4.13	5.38	4.91	0.08	-7.84
Investing Cash Flow	-77.41	-390.81	-94.18	-58.58	-161.44	-68.07
Long-Term Debt Issued	-	486.5	165.1	40.75	25.5	746.5
Long-Term Debt Repaid	-	-187.13	-110.6	-148.55	-125.5	-441
Net Debt Issued (Repaid)	21.66	299.37	54.5	-107.8	-100	305.5
Issuance of Common Stock	0.96	6.4	4.32	5.47	6.82	5.23
Repurchase of Common Stock	-5.39	-55.98	-280.86	-149.62	-4.8	-105.08
Other Financing Activities	-20.38	-11.92	-7.88	-	-0.25	-84.03
Financing Cash Flow	-3.16	237.86	-229.93	-251.95	-98.23	121.63
Foreign Exchange Rate Adjustments	8.28	-6.46	3.89	-10.72	-9.48	13.87
Net Cash Flow	17.03	-30.03	-180.26	-56.79	43.28	271.26
Free Cash Flow	-4.51	24.96	73.09	222.13	264.41	164.94
Free Cash Flow Growth	-	-65.84%	-67.09%	-15.99%	60.30%	1.88%
Free Cash Flow Margin	-0.27%	1.55%	4.74%	14.26%	17.14%	12.02%
Free Cash Flow Per Share	-0.06	0.32	0.91	2.66	3.09	1.94
Cash Interest Paid	64.4	64.4	44.3	42.2	43.2	47.3
Cash Income Tax Paid	22.7	22.7	23.6	35.9	49.5	29.8
Levered Free Cash Flow	85.91	90.15	177.71	165.64	377.4	-6.21
Unlevered Free Cash Flow	130.9	128.7	203.65	189.79	401.87	11.04
Change in Working Capital	-30.38	-31.01	-81.57	-39.42	18.16	-41.31

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q